Philip Scheltens
InvestorPartner, Head of Dementia Fund at LSP (Life Sciences Partners)
Find your path to Philip
42 people in our graph share verified history with Philip — schools, employers, funds. One of them is your warm intro.
Drew BurdonunlockedPhilip: together at LSP (Life Sciences Partners)
×11Philip: together at LSP (Life Sciences Partners)
About
Responsible advisor associated with the NewAmsterdam Pharma investment via the Dementia Fund.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Deals · 1
NewAmsterdam PharmaLed round
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at LSP (Life Sciences Partners)
Andre Olijslager
Investor at LSP (Life Sciences Partners)
Anne Portwich
Partner at EQT Life Sciences
Anton Pijpers
Investor at LSP (Life Sciences Partners)
Arno de Wilde
Investor at LSP (Life Sciences Partners)
Bas Vaessen
Investor at LSP (Life Sciences Partners)
Bruno Holthof
Investor at LSP (Life Sciences Partners)
Christoph Broja
Partner at EQT Life Sciences
Cillian King
Investor at LSP (Life Sciences Partners)
Frequently asked questions
- Who is Philip Scheltens?
- Responsible advisor associated with the NewAmsterdam Pharma investment via the Dementia Fund.
- Where does Philip Scheltens work?
- Philip Scheltens is Partner, Head of Dementia Fund at LSP (Life Sciences Partners).
- What does Philip Scheltens invest in?
- Philip Scheltens invests in Biotech, Digital Health, Healthtech, Medical Devices.
- What companies has Philip Scheltens invested in?
- Investments tracked here include NewAmsterdam Pharma.
- Does Philip Scheltens lead rounds?
- Yes — Philip Scheltens has led 1 tracked investment.